2,536
Views
19
CrossRef citations to date
0
Altmetric
Research Article

pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer

, , , , , , & show all
Pages 680-691 | Received 29 Jan 2021, Accepted 15 Mar 2021, Published online: 05 Apr 2021

References

  • Chen C, Yu Y, Wang X, et al. (2017). Manipulation of pH-sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release. Int J Biol Macromol 95:451–61.
  • Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin 66:115–32.
  • Dai L, Li X, Duan X, et al. (2019). A pH/ROS cascade-responsive charge-reversal nanosystem with self-amplified drug release for synergistic oxidation-chemotherapy. Adv Sci (Weinh) 6:1801807.
  • Feng T, Ai X, An G, et al. (2016). Charge-convertible carbon dots for imaging-guided drug delivery with enhanced in vivo cancer therapeutic efficiency. ACS Nano 10:4410–20.
  • Feng W, Zong M, Wan L, et al. (2020). pH/redox sequentially responsive nanoparticles with size shrinkage properties achieve deep tumor penetration and reversal of multidrug resistance. Biomater Sci 8:4767–78.
  • Gottesman MM, Fojo T, Bates SE. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58.
  • Guo J, Wu G, Bao J, et al. (2014). Cucurbitacin B induced ATM-mediated DNA damage causes G2/M cell cycle arrest in a ROS-dependent manner. PLoS One 9:e88140.
  • Guo Z, Sui J, Ma M, et al. (2020). pH-responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment. J Control Release 326:350–64.
  • Hu C, Zhuang W, Yu T, et al. (2020). Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy. J Mater Chem B 8:5267–79.
  • Hu J-J, Lei Q, Peng M-Y, et al. (2017). A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem. Biomaterials 128:136–46.
  • Joshi P, Vishwakarma RA, Bharate SB. (2017). Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer. Eur J Med Chem 138:273–92.
  • Kang Y, Ha W, Liu Y-Q, et al. (2014). pH-responsive polymer–drug conjugates as multifunctional micelles for cancer-drug delivery. Nanotechnology 25:335101.
  • Kim Y, Uthaman S, Pillarisetti S, et al. (2020). Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy. Acta Biomater 108:273–84.
  • Li Y, Chen M, Yao B, et al. (2019). Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy. J Mater Chem B 7:5814–24.
  • Li Y, Yang HY, Thambi T, et al. (2019). Charge-convertible polymers for improved tumor targeting and enhanced therapy. Biomaterials 217:119299.
  • Lim C, Sim T, Hoang NH, et al. (2017). A charge-reversible nanocarrier using PEG-PLL (-g-Ce6, DMA)-PLA for photodynamic therapy. Int J Nanomedicine 12:6185–96.
  • Liu J, Zhao L, Shi L, et al. (2020). A sequentially responsive nanosystem breaches cascaded bio-barriers and suppresses P-glycoprotein function for reversing cancer drug resistance. ACS Appl Mater Interfaces 12:54343–55.
  • Luan T, Cheng L, Cheng J, et al. (2019). Tailored design of an ROS-responsive drug release platform for enhanced tumor therapy via "sequential induced activation processes". ACS Appl Mater Interfaces 11:25654–63.
  • Lv S, Tang Z, Zhang D, et al. (2014). Well-defined polymer–drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. J Control Release 194:220–7.
  • Niu X, Cao J, Zhang Y, et al. (2019). A glutathione responsive nitric oxide release system based on charge-reversal chitosan nanoparticles for enhancing synergistic effect against multidrug resistance tumor. Nanomedicine 20:102015.
  • Oddone N, Pederzoli F, Duskey JT, et al. (2019). ROS-responsive “smart” polymeric conjugate: synthesis, characterization and proof-of-concept study. Int J Pharm 570:118655.
  • Ou K, Kang Y, Chen L, et al. (2019). H2O2-responsive nano-prodrug for podophyllotoxin delivery. Biomater Sci 7:2491–8.
  • Pan Q, Deng X, Gao W, et al. (2020). ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy. Colloids Surf B Biointerfaces 194:111223.
  • Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60.
  • Persidis A1. (1999). Cancer multidrug resistance. Nat Biotechnol 17:94–5.
  • Ren G, Sha T, Guo J, et al. (2015). Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells. J Nat Med 69:522–30.
  • Roy A, Ernsting MJ, Undzys E, et al. (2015). A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. Biomaterials 52:335–46.
  • Sivak L, Subr V, Tomala J, et al. (2017). Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate. Biomaterials 115:65–80.
  • Sun Y, Zhang J, Zhou J, et al. (2015). Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells. Eur J Pharmacol 768:28–40.
  • Tang S, Meng Q, Sun H, et al. (2017). Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer. Biomaterials 114:44–53.
  • Tao W, He Z. (2018). ROS-responsive drug delivery systems for biomedical applications. Asian J Pharm Sci 13:101–12.
  • Taresco V, Alexander C, Singh N, et al. (2018). Stimuli‐responsive prodrug chemistries for drug delivery. Adv Ther 1:1800030.
  • Tian H, Zhang M, Jin G, et al. (2021). Cu-MOF chemodynamic nanoplatform via modulating glutathione and H2O2 in tumor microenvironment for amplified cancer therapy. J Colloid Interface Sci 587:358–66.
  • Wang K, Yang B, Ye H, et al. (2019). Self-strengthened oxidation-responsive bioactivating prodrug nanosystem with sequential and synergistically facilitated drug release for treatment of breast cancer. ACS Appl Mater Interfaces 11:18914–22.
  • Wang K, Ye H, Zhang X, et al. (2020). An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials 257:120224.
  • Wang S, Zhang F, Yu G, et al. (2020). Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 10:6629–37.
  • Wang X, Wang X, Jin S, et al. (2019). Stimuli-responsive therapeutic metallodrugs. Chem Rev 119:1138–92.
  • Wang Y, Lv S, Deng M, et al. (2016). A charge-conversional intracellular-activated polymeric prodrug for tumor therapy. Polym Chem 7:2253–63.
  • Xu C, Song R, Lu P, et al. (2020). A pH-responsive charge-reversal drug delivery system with tumor-specific drug release and ROS generation for cancer therapy. Int J Nanomedicine 15:65–80.
  • Xu L, Yang Y, Zhao M, et al. (2018). A reactive oxygen species-responsive prodrug micelle with efficient cellular uptake and excellent bioavailability. J Mater Chem B 6:1076–84.
  • Xu X, Saw PE, Tao W, et al. (2017). ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy. Adv Mater 29:1700141.
  • Yang H, Khan AR, Liu M, et al. (2020). Stimuli-responsive polymeric micelles for the delivery of paclitaxel. J Drug Deliv Sci Technol 56:101523.
  • Yang Y, Xu L, Zhu W, et al. (2018). One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy. Biomaterials 156:121–33.
  • Yang Z, Sun N, Cheng R, et al. (2017). pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials 147:53–67.
  • Yasuda S, Yogosawa S, Izutani Y, et al. (2010). Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells. Mol Nutr Food Res 54:559–65.
  • Ye M, Han Y, Tang J, et al. (2017). A tumor-specific cascade amplification drug release nanoparticle for overcoming multidrug resistance in cancers. Adv Mater 29:1702342.
  • Yin W, Ke W, Chen W, et al. (2019). Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release. Biomaterials 195:63–74.
  • Zhang T, Li Y, Park KA, et al. (2012). Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. Autophagy 8:559–76.
  • Zhou H, Lv S, Zhang D, et al. (2018). A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity. Acta Biomater 73:388–99.
  • Zhou J, Yu G, Huang F. (2017). Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future. Chem Soc Rev 46:7021–53.
  • Zhou Q, Zhang L, Yang T, et al. (2018). Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine 13:2921–42.
  • Zhou Y, Ren X, Hou Z, et al. (2021). Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation. Nanoscale Horiz 6:120–31.